Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector-Reference-Cited by-同舟云学术

Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector

Published:2014-02 Issue:8 Volume:32 Page:938-943
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Batchu Ramesh B.,Gruzdyn Oksana V.,Moreno-Bost Amberly M.,Szmania Susann,Jayandharan Giridhararao,Srivastava Arun,Kolli Bala K.,Weaver Donald W.,van Rhee Frits,Gruber Scott A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference41 articles.

1. Cancer statistics, 2013;Siegel;CA: Cancer J Clin,2013

2. Survival rates for International Federation of Gynecology and Obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review;Seidman;Int J Gynecol Cancer,2012

3. Decisions about dendritic cells: past, present, and future;Steinman;Annu Rev Immunol,2012

4. Engineering dendritic cells to enhance cancer immunotherapy;Boudreau;Mol Ther,2011

5. Cancer immunotherapy with mRNA-transfected dendritic cells;Gilboa;Immunol Rev,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential value of cancer‐testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy;Immunity, Inflammation and Disease;2024-06

2. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?;Cancers;2023-03-15

3. Nucleic acid vaccination strategies for ovarian cancer;Frontiers in Bioengineering and Biotechnology;2022-11-07

4. When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies;Frontiers in Oncology;2022-02-23

5. Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering;Molecular Therapy - Oncolytics;2021-12